Folgen
Florian Heitz
Florian Heitz
Oberarzt der Kliniken Essen-Mitte
Bestätigte E-Mail-Adresse bei kem-med.com
Titel
Zitiert von
Zitiert von
Jahr
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ...
Nature genetics 45 (4), 371-384, 2013
6472013
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer
PDP Pharoah, YY Tsai, SJ Ramus, CM Phelan, EL Goode, K Lawrenson, ...
Nature genetics 45 (4), 362-370, 2013
4182013
Identification of six new susceptibility loci for invasive epithelial ovarian cancer
KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ...
Nature genetics 47 (2), 164-171, 2015
3092015
Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases
F Heitz, P Harter, HJ Lueck, A Fissler-Eckhoff, F Lorenz-Salehi, ...
European journal of cancer 45 (16), 2792-2798, 2009
2932009
Treatment of recurrent ovarian cancer
S Pignata, SC Cecere, A Du Bois, P Harter, F Heitz
Annals of Oncology 28, viii51-viii56, 2017
2702017
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS
MC Southey, DE Goldgar, R Winqvist, K Pylkäs, F Couch, M Tischkowitz, ...
Journal of medical genetics 53 (12), 800-811, 2016
2402016
Impact of a structured quality management program on surgical outcome in primary advanced ovarian cancer
P Harter, ZM Muallem, C Buhrmann, D Lorenz, C Kaub, R Hils, ...
Gynecologic oncology 121 (3), 615-619, 2011
2362011
Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer. An analysis of the AGO Study Group metadatabase
JP Grabowski, P Harter, F Heitz, E Pujade-Lauraine, A Reuss, ...
Gynecologic oncology 140 (3), 457-462, 2016
1962016
Genome-wide meta-analyses of breast, ovarian, and prostate cancer association studies identify multiple new susceptibility loci shared by at least two cancer types
SP Kar, J Beesley, A Amin Al Olama, K Michailidou, J Tyrer, ZS Kote-Jarai, ...
Cancer discovery 6 (9), 1052-1067, 2016
1912016
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer
H Shen, BL Fridley, H Song, K Lawrenson, JM Cunningham, SJ Ramus, ...
Nature communications 4 (1), 1628, 2013
1792013
Pre-operative serum albumin is associated with post-operative complication rate and overall survival in patients with epithelial ovarian cancer undergoing cytoreductive surgery
B Ataseven, A du Bois, A Reinthaller, A Traut, F Heitz, S Aust, S Prader, ...
Gynecologic oncology 138 (3), 560-565, 2015
1672015
Neoadjuvant chemotherapy in advanced ovarian cancer: on what do we agree and disagree?
I Vergote, A du Bois, F Amant, F Heitz, K Leunen, P Harter
Gynecologic oncology 128 (1), 6-11, 2013
1642013
Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1)
P Harter, J Hauke, F Heitz, A Reuss, S Kommoss, F Marmé, A Heimbach, ...
PloS one 12 (10), e0186043, 2017
1612017
Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium
CM Nagle, SC Dixon, A Jensen, SK Kjaer, F Modugno, A DeFazio, ...
British journal of cancer 113 (5), 817-826, 2015
1582015
Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21. 31
J Permuth-Wey, K Lawrenson, HC Shen, A Velkova, JP Tyrer, Z Chen, ...
Nature communications 4 (1), 1627, 2013
1372013
ABCA Transporter Gene Expression and Poor Outcome in Epithelial Ovarian Cancer
EL Hedditch, B Gao, AJ Russell, Y Lu, C Emmanuel, J Beesley, ...
JNCI: Journal of the National Cancer Institute 106 (7), dju149, 2014
1342014
Shared heritability and functional enrichment across six solid cancers
X Jiang, HK Finucane, FR Schumacher, SL Schmit, JP Tyrer, Y Han, ...
Nature communications 10 (1), 431, 2019
1172019
Genome-wide significant risk associations for mucinous ovarian carcinoma
Australian Ovarian Cancer Study Group, H Baker, EV Bandera, Y Bean, ...
Nature genetics 47 (8), 888-897, 2015
1172015
Lavage of the uterine cavity for molecular detection of Müllerian duct carcinomas: a proof-of-concept study
E Maritschnegg, Y Wang, N Pecha, R Horvat, E Van Nieuwenhuysen, ...
Journal of Clinical Oncology 33 (36), 4293, 2015
1142015
BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers
HD Meeks, H Song, K Michailidou, MK Bolla, J Dennis, Q Wang, ...
Journal of the National Cancer Institute 108 (2), djv315, 2016
1032016
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20